Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related BSX
Boston Scientific Initiates Global Study To Assess EMBLEM Subcutaneous Implantable Defibrillator In Primary Prevention Patients With Low Ejection Fraction
New Data Demonstrate Greater Pain Relief With Boston Scientific Precision Spectra™ Spinal Cord Stimulator System
Related MA
Credit Card Companies Blacklist Due To Sex Trafficking Allegations
Mastercard Remains 'Core Holding' For SunTrust
Leave the credit card (Investor's Business Daily)

Pre-open movers US stock futures are lower this morning, as investors are awaiting economic data. Futures for the Dow Jones Industrial Average dropped 20 points to 13,413.00 and S&P 500 index futures fell 3.60 points to 1,460.70. Nasdaq 100 futures declined 5 points to 2,723.75.

A Peek Into Global Markets European markets were mostly lower today. The STOXX Europe 600 Index fell 0.03%, London's FTSE 100 Index gained 0.05%, German DAX 30 Index dropped 0.21% and French CAC 40 Index fell 0.23%.

Asian markets ended mostly higher, with Japan's Nikkei Stock Average rising 0.72%, China's Shanghai Composite jumping 0.60% and Australia's S&P/ASX 200 Index dropping 0.06%. Hong Kong's Hang Seng Index fell 0.14% and India's Sensex surged 0.40%.

Broker Recommendation Analysts at Credit Suisse upgraded Boston Scientific (NYSE: BSX) from “neutral” to “outperform.” The target price for Boston Scientific has been raised from $6 to $7.50.

Boston Scientific shares dropped 0.63% to close at $6.32 yesterday.

Breaking news

  • MasterCard (NYSE: MA) and Equity Bank of Kenya today announced an agreement at a signing ceremony in Nairobi to issue five-million MasterCard-branded debit and prepaid cards, over the next 18 months. To read the full news, click here.
  • Lennar (NYSE: LEN) reported upbeat fourth-quarter profit. To read the full news, click here.
  • As organizations of all types look to accelerate the adoption of video-based communications and video-enabled business processes, AT&T (NYSE: T) and Polycom (NASDAQ: PLCM) announced today a strategic agreement to personalize, mobilize and virtualize video meetings. To read the full news, click here.
  • Pluristem Therapeutics (NASDAQ: PSTI) announced today that the Paul-Ehrlich-Institute (PEI), the medical regulatory body for biological medicinal products for the Federal Republic of Germany, has approved the company's request to initiate a Phase II study using PLX-PAD cells in patients suffering from Intermittent Claudication (IC). To read the full news, click here.

Posted-In: Credit Suisse US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (BSX + LEN)

Around the Web, We're Loving...

Get Benzinga's Newsletters